Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Alzheimer Disease

Alzheimer's Disease - Scenario Forecasts Reveal a Future Upper Limit Market Value of $12.7 Billion to a Lower Limit Value of $1.9 Billion across the Seven Major Markets in 2017

With the AD market entering a pivotal phase, We have conducted several scenario forecasts in order to explore the possible market outlook over the next 10 years. Several pioneering Phase III disease slowing therapies offer blockbuster potential. However, should these drugs fail Phase III trials, generic competition of current therapies will see the market value decline.

Keywords: Alzheimer Disease, Research and Markets.

...

• View Other Issues of Health Business Week
  
• View Other NewsRx Publications